We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KKR:NYSEKKR & Co. Inc. Analysis

Data as of 2026-07-09 - not real-time

$96.27

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

KKR’s stock is trading at $96.27, comfortably above its 20‑day SMA ($94.51) and just north of the 50‑day SMA ($96.22), suggesting short‑term price strength, yet it remains well below the 200‑day SMA ($109.68) and the technical trend is flagged as bearish. Momentum indicators are mixed: the RSI sits at a neutral 53.9, while the MACD line has crossed above its signal, generating a bullish histogram. The equity exhibits high volatility (30% 30‑day) and a beta above 1.5, implying pronounced market sensitivity. Fundamentally, revenue has contracted 6.6% YoY, but margins stay healthy (gross 55.5%, operating 11%). The forward PE of ~13 contrasts sharply with a trailing PE of 32.7, indicating that earnings are expected to accelerate, a view supported by analysts’ 30% upside target of $125.
Recent news highlights the launch of the $10 billion Helix Digital Infrastructure platform, positioning KKR to capture growth in data‑center and power‑generation assets, while a “Strong Buy” upgrade underscores market optimism. However, the firm carries a sizable debt load ($55.8 B) offset by a strong cash balance ($45.3 B) and a modest dividend yield of 0.8% with a 25% payout ratio, suggesting dividend sustainability but ongoing leverage concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Pending Q2 earnings release could clarify earnings trajectory
  • Technical momentum from MACD crossover versus bearish longer‑term trend
  • Current price near resistance level with high volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward earnings expansion reflected in low forward PE
  • Helix Digital Infrastructure pipeline driving growth opportunities
  • Analyst consensus target implying ~30% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified global asset base and exposure to high‑margin sectors
  • Sustainable dividend with low payout ratio and strong cash position
  • Strategic positioning in private equity, credit and infrastructure markets

Key Metrics & Analysis

Financial Health

Revenue Growth-6.60%
Profit Margin11.68%
P/E Ratio32.7
ROE7.66%
ROA1.46%
Debt/Equity69.03
P/B Ratio3.1
Op. Cash Flow$-325296000
Industry P/E17.6

Technical Analysis

TrendBearish
RSI53.9
Support$88.23
Resistance$101.05
MA 20$94.51
MA 50$96.22
MA 200$109.68
MACDBullish
VolumeStable
Fear & Greed Index93.14

Valuation

Target Price$125.29
Upside/Downside30.15%
GradeFair
TypeBlend
Dividend Yield0.80%

Risk Assessment

Beta1.51
Volatility34.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.